Dyne Therapeutics, Inc.
USD17.24
-1.39 (-7.46%)
CEO
John G. Cox
IPO Date
2020-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$18.30
Prev. Close
$18.63
Day Low
$16.96
Day High
$18.48
52W Low
$8.06
52W High
$25.00
Market Cap
$2.85B
Volume
1.81M
| 2,500 |
| $17.12 |
| 14 May 2026 | Friedl-Naderer Johanna | Chief Commercial Officer | S-Sale | Disposed | 228 | $18.36 |
| 14 May 2026 | Kerr Douglas | Chief Medical Officer | S-Sale | Disposed | 1,564 | $18.36 |
| 14 May 2026 | Lucera Erick | Chief Financial Officer | S-Sale | Disposed | 1,448 | $18.36 |
| 14 May 2026 | Cox John | director, officer: CEO & President | S-Sale | Disposed | 3,311 | $18.36 |
| 6 May 2026 | Rhodes Jason P | director | S-Sale | Disposed | 3,136 | $18.00 |
| 6 May 2026 | Rhodes Jason P | director | S-Sale | Disposed | 6,241 | $18.00 |
| 6 May 2026 | Rhodes Jason P | director | S-Sale | Disposed | 61 | $18.00 |
| 6 May 2026 | Rhodes Jason P | director | S-Sale | Disposed | 2,466 | $18.00 |